ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,362Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 1383

$1.09M Total Retail Price of All Prescriptions

Rank: 44 out of 1383

635 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 635 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 635 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 19,085 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
OMEPRAZOLE 1,083 891 1 5
LISINOPRIL 934 749 2 3
LEVOTHYROXINE SODIUM 922 799 3 4
HYDROCODONE-ACETAMINOPHEN 778 510 S3 4 1
SIMVASTATIN 771 641 5 2
CITALOPRAM HBR 707 571 6 15
PRAVASTATIN SODIUM 654 486 7 14
FUROSEMIDE 559 447 8 7
METOPROLOL TARTRATE 541 439 9 9
AMLODIPINE BESYLATE 516 450 10 6
METFORMIN HCL 509 393 11 8
WARFARIN SODIUM 483 386 12 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 407 386 13 27
POTASSIUM CHLORIDE 372 327 14 12
ZOLPIDEM TARTRATE 350 275 15 17
HYDROCHLOROTHIAZIDE 346 277 16 10
SERTRALINE HCL 327 236 17 21
CARVEDILOL 327 247 17 24
GABAPENTIN 309 204 19 11
ATENOLOL 268 232 20 16
METOPROLOL SUCCINATE 258 209 21 29
RANITIDINE HCL 250 196 22 19
GLIMEPIRIDE 246 168 23 31
LOSARTAN POTASSIUM 238 197 24 23
MIRTAZAPINE 229 190 25 51
PREDNISONE 217 191 26 40
DONEPEZIL HCL 213 200 27 35
FENTANYL 211 154 S2 28 92
LANTUS 203 178 29 50
ALENDRONATE SODIUM 197 171 30 37
ATORVASTATIN CALCIUM 195 138 31 18
MELOXICAM 165 139 32 20
DIOVAN 164 107 33 58
DIGOXIN 162 162 34 59
NABUMETONE 161 127 35 156
TAMSULOSIN HCL 141 112 36 30
TRAMADOL HCL 140 118 37 25
CYMBALTA 139 98 38 53
HYDRALAZINE HCL 130 126 39 86
HYDROXYCHLOROQUINE SULFATE 128 87 40 264
VENTOLIN HFA 127 103 41 93
INSULIN SYRINGE 124 91 42 83
OXYCODONE-ACETAMINOPHEN 123 84 S2 43 107
FINASTERIDE 121 109 44 121
SPIRIVA 115 109 45 45
ADVAIR DISKUS 114 73 46 63
ENDOCET 113 69 S2 47 97
FLUTICASONE PROPIONATE 112 86 48 39
ESTRADIOL 109 83 R 49 96
AMOX TR-POTASSIUM CLAVULANATE 108 80 50 106
AMLODIPINE BESYLATE-BENAZEPRIL 108 108 50 68
NEXIUM 106 63 52 26
CILOSTAZOL 106 98 52 231
NIFEDIPINE ER 103 93 54 126
EVISTA 102 78 55 152
TIZANIDINE HCL 101 35 56 104
LOSARTAN-HYDROCHLOROTHIAZIDE 100 96 57 60
VESICARE 100 86 57 182
METHOTREXATE 100 72 57 256
CEFUROXIME 100 90 57 164
CIPROFLOXACIN HCL 98 76 61 54
LOVASTATIN 98 86 61 22
BUSPIRONE HCL 94 59 63 109
TRAZODONE HCL 93 74 64 36
ISOSORBIDE MONONITRATE ER 93 77 64 66
SINGULAIR 92 71 66 82
MORPHINE SULFATE ER 90 23 S2 67 77
TRICOR 88 71 68 125
LYRICA 87 58 69 72
JANTOVEN 85 85 70 146
JANUVIA 84 27 71 85
PRAMIPEXOLE DIHYDROCHLORIDE 84 69 71 160
PAROXETINE HCL 84 55 71 55
ONDANSETRON HCL 83 74 74 212
PHENYTOIN SODIUM EXTENDED 83 26 74 137
LEVOFLOXACIN 81 62 76 88
TRIAMCINOLONE ACETONIDE 81 71 76 159
NAMENDA 80 80 78 49
PROAIR HFA 78 50 79 42
AGGRENOX 77 77 80 191
KLOR-CON 10 77 56 80 74
ZETIA 77 69 80 101
FENOFIBRATE 76 74 83 65
AZITHROMYCIN 75 63 84 41
DIOVAN HCT 75 44 84 103
PLAVIX 75 55 84 43
OXYCODONE HCL-ACETAMINOPHEN 73 60 S2 87 81
POLYETHYLENE GLYCOL 3350 70 49 88 64
BENAZEPRIL HCL 70 49 88 38
CLONIDINE HCL 69 50 90 44
CEFDINIR 69 55 90 171
PROPRANOLOL HCL 67 59 92 129
COMBIVENT 64 56 93 116
DIVALPROEX SODIUM 64 40 93 78
CARBIDOPA-LEVODOPA 63 55 95 108
MONTELUKAST SODIUM 62 45 96 162
NIASPAN 62 49 96 148
CLOPIDOGREL 62 34 96 28
FAMOTIDINE 61 45 99 61
RAMIPRIL 61 45 99 80
ALLOPURINOL 60 60 101 33
PANTOPRAZOLE SODIUM 59 44 102 32
OLANZAPINE 58 51 103 164
PROMETHAZINE HCL 56 0 R 104 56
TRIAMTERENE-HCTZ 55 22 105 48
NITROFURANTOIN 55 55 105 187
NYSTATIN 53 49 107 132
METOCLOPRAMIDE HCL 51 35 108 127
DOXAZOSIN MESYLATE 51 51 108 120
ATENOLOL-CHLORTHALIDONE 51 48 108 149
CRESTOR 50 50 111 34
RISPERIDONE 50 47 111 71
GLYBURIDE 50 22 R 111 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.